4.7 Article

Engineered Streptomyces platensis Strains That Overproduce Antibiotics Platensimycin and Platencin

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 53, Issue 4, Pages 1299-1304

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01358-08

Keywords

-

Funding

  1. MERC
  2. University of Wisconsin- Madison
  3. NIH [T32 GM008349.]

Ask authors/readers for more resources

Platensimycin, which is isolated from Streptomyces platensis MA7327, and platencin, which is isolated from S. platensis MA7339, are two recently discovered natural products that serve as important antibiotic leads. Here we report on the identification of S. platensis MA7327 as a dual producer of both platensimycin and platencin. A PCR-based approach was used to locate and clone the locus involved in platensimycin and platencin production, including ptmR1, which encodes a putative GntR-like transcriptional regulator. Deletion of this gene from the producing organism allowed us to isolate strains that overproduce platensimycin and platencin with yields of 323 +/- 29 mg/liter and 255 +/- 30 mg/liter, respectively. These results illustrate the effectiveness of genetic manipulation for the rational engineering of improvements in titers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available